254 related articles for article (PubMed ID: 25327886)
1. Non-spherical micro- and nanoparticles: fabrication, characterization and drug delivery applications.
Mathaes R; Winter G; Besheer A; Engert J
Expert Opin Drug Deliv; 2015 Mar; 12(3):481-92. PubMed ID: 25327886
[TBL] [Abstract][Full Text] [Related]
2. The effects of polymeric nanostructure shape on drug delivery.
Venkataraman S; Hedrick JL; Ong ZY; Yang C; Ee PL; Hammond PT; Yang YY
Adv Drug Deliv Rev; 2011 Nov; 63(14-15):1228-46. PubMed ID: 21777633
[TBL] [Abstract][Full Text] [Related]
3. The effect of particle shape on cellular interaction and drug delivery applications of micro- and nanoparticles.
Jindal AB
Int J Pharm; 2017 Oct; 532(1):450-465. PubMed ID: 28917985
[TBL] [Abstract][Full Text] [Related]
4. Adaptive micro and nanoparticles: temporal control over carrier properties to facilitate drug delivery.
Yoo JW; Doshi N; Mitragotri S
Adv Drug Deliv Rev; 2011 Nov; 63(14-15):1247-56. PubMed ID: 21605607
[TBL] [Abstract][Full Text] [Related]
5. Particle shape effects in vitro and in vivo.
Harris BJ; Dalhaimer P
Front Biosci (Schol Ed); 2012 Jun; 4(4):1344-53. PubMed ID: 22652876
[TBL] [Abstract][Full Text] [Related]
6. The effect of particle shape and size on cellular uptake.
Zheng M; Yu J
Drug Deliv Transl Res; 2016 Feb; 6(1):67-72. PubMed ID: 26679196
[TBL] [Abstract][Full Text] [Related]
7. Designer nanoparticles: incorporating size, shape and triggered release into nanoscale drug carriers.
Caldorera-Moore M; Guimard N; Shi L; Roy K
Expert Opin Drug Deliv; 2010 Apr; 7(4):479-95. PubMed ID: 20331355
[TBL] [Abstract][Full Text] [Related]
8. Co-opting Moore's law: Therapeutics, vaccines and interfacially active particles manufactured via PRINT®.
DeSimone JM
J Control Release; 2016 Oct; 240():541-543. PubMed ID: 27423326
[TBL] [Abstract][Full Text] [Related]
9. Application of different analytical methods for the characterization of non-spherical micro- and nanoparticles.
Mathaes R; Winter G; Engert J; Besheer A
Int J Pharm; 2013 Sep; 453(2):620-9. PubMed ID: 23727141
[TBL] [Abstract][Full Text] [Related]
10. Shape matters when engineering mesoporous silica-based nanomedicines.
Hao N; Li L; Tang F
Biomater Sci; 2016 Apr; 4(4):575-91. PubMed ID: 26818852
[TBL] [Abstract][Full Text] [Related]
11. The importance of nanoparticle shape in cancer drug delivery.
Truong NP; Whittaker MR; Mak CW; Davis TP
Expert Opin Drug Deliv; 2015 Jan; 12(1):129-42. PubMed ID: 25138827
[TBL] [Abstract][Full Text] [Related]
12. Influence of particle geometry and PEGylation on phagocytosis of particulate carriers.
Mathaes R; Winter G; Besheer A; Engert J
Int J Pharm; 2014 Apr; 465(1-2):159-64. PubMed ID: 24560647
[TBL] [Abstract][Full Text] [Related]
13. Nanoparticles for drug delivery: the need for precision in reporting particle size parameters.
Gaumet M; Vargas A; Gurny R; Delie F
Eur J Pharm Biopharm; 2008 May; 69(1):1-9. PubMed ID: 17826969
[TBL] [Abstract][Full Text] [Related]
14. Particle morphology: an important factor affecting drug delivery by nanocarriers into solid tumors.
Wang Z; Wu Z; Liu J; Zhang W
Expert Opin Drug Deliv; 2018 Apr; 15(4):379-395. PubMed ID: 29264946
[TBL] [Abstract][Full Text] [Related]
15. Solid lipid nanoparticles for parenteral drug delivery.
Wissing SA; Kayser O; Müller RH
Adv Drug Deliv Rev; 2004 May; 56(9):1257-72. PubMed ID: 15109768
[TBL] [Abstract][Full Text] [Related]
16. Role of nanoparticle size, shape and surface chemistry in oral drug delivery.
Banerjee A; Qi J; Gogoi R; Wong J; Mitragotri S
J Control Release; 2016 Sep; 238():176-185. PubMed ID: 27480450
[TBL] [Abstract][Full Text] [Related]
17. Nanoparticles for drug delivery: review of the formulation and process difficulties illustrated by the emulsion-diffusion process.
Moinard-Checot D; Chevalier Y; Briançon S; Fessi H; Guinebretière S
J Nanosci Nanotechnol; 2006; 6(9-10):2664-81. PubMed ID: 17048474
[TBL] [Abstract][Full Text] [Related]
18. Physical and chemical strategies for therapeutic delivery by using polymeric nanoparticles.
Morachis JM; Mahmoud EA; Almutairi A
Pharmacol Rev; 2012 Jul; 64(3):505-19. PubMed ID: 22544864
[TBL] [Abstract][Full Text] [Related]
19. Sucrose ester stabilized solid lipid nanoparticles and nanostructured lipid carriers. I. Effect of formulation variables on the physicochemical properties, drug release and stability of clotrimazole-loaded nanoparticles.
Das S; Ng WK; Tan RB
Nanotechnology; 2014 Mar; 25(10):105101. PubMed ID: 24531790
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo characterization of pharmaceutical nanocarriers used for drug delivery.
Jain AK; Thareja S
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):524-539. PubMed ID: 30784319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
